𝔖 Bobbio Scriptorium
✦   LIBER   ✦

669 CHARACTERIZATION OF PROTEASE INHIBITOR RESISTANCE MUTATIONS IN UNTREATED PATIENTS INFECTED WITH GENOTYPE 1B HEPATITIS C VIRUS

✍ Scribed by H. Shindo; S. Maekawa; M. Miura; K. Komase; M. Kadokura; R. Sueki; F. Amemiya; T. Kitamura; T. Inoue; M. Sakamoto; S.-I. Okada; N. Enomoto

Book ID
117378754
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
47 KB
Volume
52
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Characterization of resistance to the pr
Characterization of resistance to the protease inhibitor boceprevir in hepatitis C virus–infected patients
✍ Simone Susser; Christoph Welsch; Yalan Wang; Markus Zettler; Francisco S. Doming πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 543 KB

Boceprevir is a hepatitis C virus (HCV) nonstructural protein (NS) 3/4A protease inhibitor that is currently being evaluated in combination with peginterferon alfa-2b and ribavirin in phase 3 studies. The clinical resistance profile of boceprevir is not characterized in detail so far. The NS3 protea

Genetic heterogeneity of the NS3 proteas
Genetic heterogeneity of the NS3 protease gene in hepatitis C virus genotype 1 from untreated infected patients
✍ Sophie Vallet; Stephanie Gouriou; Jean-Baptiste Nousbaum; Marie-Christine Legran πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 242 KB πŸ‘ 2 views

## Abstract NS3 protease is essential for hepatitis C Virus (HCV) replication, and is one of the most promising targets for specific anti‐HCV therapy. Its natural polymorphism has not been studied at the quasispecies level. In the present work, the genetic heterogeneity of the NS3 protease gene was